A real-world study presented at finds zuranolone's PPD symptom improvements were sustained through day 90.
|Articles|October 27, 2020
- Vol 65 No 10
- Volume 65
- Issue 10
What did you think of this month’s cover story? October 2020
Let us know: Send us a message on Facebook, Twitter, or send an email to our editorial staff.
Advertisement
In the second installment of a 2-part Infertility series, ‘
Read Part 1 here:
Let us know: Send us a message on
Articles in this issue
almost 6 years ago
Mental health support is critical during pandemicalmost 6 years ago
Was this a failure to diagnose ovarian failure?almost 6 years ago
Stand firm with sciencealmost 6 years ago
Vulvar infection in patient with acute myeloid leukemiaalmost 6 years ago
Choosing the right pillalmost 6 years ago
Treatment of the infertile couplealmost 6 years ago
An imaging approach to early pregnancy failurealmost 6 years ago
Age of anxietyalmost 6 years ago
Test your knowledge of this rare vulvar conditionAdvertisement
Related to this article
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA holding public meeting on testosterone use in menopausal women
2
Survey: 51% of US-women report negative healthcare experiences
3
Contemporary OB/GYN Weekly Review: Testosterone evidence, ECV counseling, and more
4
Zuranolone shows sustained PPD symptom improvement through day 90
5